Western blot (n = 20) and immunohistochemistry (n = 92) in breast cancer patients indicated an inverse relationship between SVCT2 protein levels in tumor tissue and hormone receptor status, with low SVCT2 levels in normal tissue (69), again without ascorbate measurements. This evidence concerns the gene SLC23A2 and breast carcinoma.